Heterogeneity in susceptibility to metronidazole among Helicobacter pylori isolates from patients with gastritis or peptic ulcer disease

Journal of Clinical Microbiology

Volumn 34, Issue 9, 1996, Pages 2158-2162

  Weel, J F L ^a   Van Der Hulst, R W M ^a   Gerrits, Y ^a   Tytgat, G N J ^a   Van Der Ende, A ^a   Dankert, J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE;

ADULT; ARTICLE; DRUG RESISTANCE; DRUG SENSITIVITY; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; PEPTIC ULCER; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA;

HELICOBACTER PYLORI; NEGIBACTERIA;

EID: 0029742104     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.9.2158-2162.1996     Document Type: Article

References (24)

1. Akyopantz, N., N. O. Bukanov, T. U. Westblom, S. Kresovich, and D. E. Berg. 1992. DNA diversity among clinical isolates of H. pylori detected by PCR-based RAPD fingerprinting. Nucleic Acid Res. 20:5137-5142.
2. Cederbrant, G., G. Kahlmeter, and A. Ljungh. 1992. Proposed mechanism for MTZ resistance in Helicobacter pylori. J. Antimicrob. Chemother. 29: 115-120.
3. Edwards, D. I., J. H. Tocher, L. Dale, D. A. Widdick, and N. S. Virk. 1990. Effect on DNA of bioreducible nitroimidazole and benzotriazine drugs, p. 275-283. In G. E. Adams, A. Breccia, M. Fielden, and P. Wardman (ed.), Selective activation of drugs by redox processes. Plenum Press, New York.
4. Glupczynski, Y., A. Burrette, E. de Koster, J. F. Nyst, M. Deltener, S. Cadranel, B. L. Bordeaux, and D. de Vos. 1990. Metronidazole resistance in Helicobacter pylori. Lancet 335:976-977.
5. Hirschl, A. M., M. M. Hirschl, and M. L. Rotter. 1993. Comparison of three methods of the sensitivity of Helicobacter pylori to metronidazole. J. Antimicrob. Chemother. 32:45-49.
6. Kuipers, E. J., A. M. Uyterlinde, A. S. Pena, R. Roosendaal, G. Pals, C. W. J. van Uffelen, G. F. Nelis, H. P. M. Festen, and S. G. M. Meuwissen. 1995. Long term sequelae of Helicobacter pylori gastritis. Lancet 345:1525-1528.
7. Langenberg, W., E. A. J. Raum, A. Widjojokusumo, G. N. J. Tytgat, and H. C. Zanen. 1986. Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis. J. Clin. Microbiol. 24:414-417.
8. Logan, R. P. H., P. A. Gummett, J. J. Misiewicz, Q. N. Karim, M. M. Walker, and J. H. Baron. 1991. One week eradication regimen for Helicobacter pylori. Lancet 336:1249-1252.
9. Madiraju, M. V. V. S., D. P. Brunner, and B. J. Wilkinson. 1987. Effects of temperature, NaCl, and methicillin on penicillin-binding proteins, growth, peptidoglycan synthesis, and autolysis in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 31:1727-1733.
10. Marshall, B. J. 1994. Helicobacler pylori. Am. J. Gastroenterol. 89(Suppl.): 116-128.
11. Noach, L. A., W. Langenberg, M. A. Bertola, J. Dankert, and G. N. J. Tytgat. 1994. Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand. J. Gastroenterol. 26:321-327.
12. Oudbier, J. H., W. Langenberg, E. A. J. Rauws, and C. Bruin-Mosch. 1990. Genotypical variation of Campylobacter pylori from gastric mucosa. J. Clin. Microbiol. 28:559-565.
13. Owen, R. J., G. D. Bell, M. Desai, M. Moreno, P. W. Gant, J. H. Jones, and D. Linton. 1993. Biotype and molecular fingerprints of metronidazole resistant strains of Helicobacter pylori from antral gastric mucosa. J. Med. Microbiol. 38:6-12.
14. Rauws, E. A. J., W. Langenberg, H. J. Houthoff, H. C. Zanen, and G. N. J. Tytgat. 1988. Campylobacter pyloridis associated chronic antral gastritis. Gastroenterology 94:33-40.
15. Ryffel, C., A. Strässle, F. H. Kayser, and B. Berger-Bächi. 1994. Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 38:724-728.
16. Smith, M. A., and D. I. Edwards. 1995. Redox potential and oxygen concentration as factors in susceptibility of Helicobacter pylori to nitroheterocyclic drugs. J. Antimicrob. Chemother. 35:751-764.
17. Stolte, M. 1992. Helicobacter pylori and gastric MALT lymphoma. Lancet 339:745-756.
18. Taylor, N. S., J. G. Fox, N. S. Akopyants, D. E. Berg, N. Thompson, B. Shames, L. Yan, E. Fontham, F. Janney, F. M. Hunter, and P. Correa. 1995. Long-term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting. J. Clin. Microbiol. 33:918-923.
19. van der Hulst, R. W. M., J. Keller, E. A. Rauws, and G. N. J. Tytgat. 1996. Treatment of H. pylori infection: a review of the world literature. Helicobacter 1:6-19.
20. van der Hulst, R. W. M., J. F. L. Weel, S. B. Verheul, J. J. Keller, F. J. W. ten Kate, A. van der Ende, E. A. J. Rauws, J. Dankert, and G. N. J. Tytgat. 1996. Treatment of H. pylori infection with low or high dose omeprazole combined with amoxicillin and the effect of early retreatment: a prospective randomized double blind study. Aliment. Pharmacol. Ther. 10:165-171.
21. van Zwet, A. A., J. C. Thijs, W. Schievink-de Vries, J. Schiphuis, and J. A. M. Snijdtr. 1994. In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 38:360-362.
22. Weel, J. F. L., R. W. M. van der Hulst, Y. Gerrits, P. Roorda, M. Feller, J. Dankert, G. N. J. Tytgat, and A. van der Ende. 1996. The interrelation between cytotoxin associated gene A, vacuolating cytotoxin and H. pylori related diseases. J. Infect. Dis. 173:1171-1175.
23. Xia, H., C. T. Keane, S. Seattle, and C. A. O'Morain. 1994. Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori. Antimicrob. Agents Chemother. 38:2357-2361.
24. Xia, H. A., C. T. Keane, S. Beattie, and C. A. O'Morain. 1994. Culture of Helicobacter pylori under aerobic conditions on solid media. Eur. J. Clin. Microbiol. Infect. Dis. 13:406-409.